Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Trial Evaluating TG4050 in Ovarian Carcinoma. [Phase 1]
Phase 1 trial evaluating TG4050 for ovarian cancer (including fallopian tube and peritoneal cancers) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [EARLY_Phase 1]
This clinical trial update reports the completion of an early-phase Phase 1 vaccine therapy trial for patients with Stage IIIC-IV ovarian ep…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of stereotactic body radiation therapy for recurrent primary ovarian or uterine cancer…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating quality of life after hyperthermic intraperitoneal chemotherapy in advanced ovarian, fallopian tube, and primary pe…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer [Phase 1]
Phase 1 study evaluating STRO-002 in combination with bevacizumab for epithelial ovarian cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluating the combination of durvalumab and tremelimumab in participants with recurrent or treatment-refractory ovarian, fa…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Nudge to Gynecologic Oncology [NA]
A clinical trial update indicating the gynecologic oncology study is currently active but not recruiting, with conditions including ovarian …
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) [Phase 3]
A Phase 3 study assessing nemvaleukin alfa in combination with pembrolizumab for platinum-resistant ovarian cancer has been terminated. Resu…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating outcomes after secondary cytoreductive surgery with or without carboplatin-based HIPEC, followed by systemic chemot…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers [Phase 1]
This clinical trial update summarizes the Phase 1 study of STRO-002, an anti-Folate Receptor Alpha antibody-drug conjugate, in ovarian and e…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial of FT538 for recurrent ovarian, fallopian tube, and primary peritoneal cancer has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a T-cell therapy in combination with nivolumab, relatlimab, and ipilimumab in metastatic ovarian cancer and rel…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients [NA]
A Mayo Clinic–sponsored clinical trial evaluating prehabilitation for patients with advanced ovarian, fallopian tube, or primary peritoneal …
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone [Phase 2]
Phase 2 study of Onapristone ER alone or with Anastrozole in progesterone-responsive gynecologic cancers has completed. Results were posted …
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum [Phase 2]
Phase 2 clinical trial update for I-131 Omburtamab in Desmoplastic Small Round Cell Tumor and other peritoneal cancers; the study is current…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating MV-NIS infected mesenchymal stem cells for recurrent ovarian, primary peritoneal, or fallopian tube cancer. Res…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial comparing MORAb-202 to investigator's choice chemotherapy in women with platinum-resistant high-grade serous ovarian cancer an…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial update describing a study on personalized timing of interval debulking surgery for advanced ovarian cancer; recruitment is ong…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Biomarker Screening Protocol for Participants With Solid Tumors
A clinical trial update describes a biomarker screening protocol for participants with solid tumors, and the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 4]
A Phase 4 interventional trial evaluating Avastin (bevacizumab) in advanced or metastatic ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy [Phase 3]
A Phase 3 trial update reports results for maintenance therapy with rucaparib and nivolumab in ovarian cancer patients who responded to fron…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This document reports the termination of a Phase 1/2 trial of AVB-S6-500 in combination with durvalumab for platinum-resistant or recurrent …
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer [Phase 2]
Phase 2 European trial evaluating enhanced DNA repair inhibition in ovarian cancer has completed enrollment and posted results. The study al…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating the safety of KAND567 in combination with carboplatin in w…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies [Phase 1]
A Phase Ib safety study of Selinexor (KPT-330) in combination with standard chemotherapy or immunotherapy agents for patients with advanced …